FRET analysis of in vivo dimerization by RNA-editing enzymes
- PMID: 16618704
- DOI: 10.1074/jbc.M511831200
FRET analysis of in vivo dimerization by RNA-editing enzymes
Abstract
Members of the ADAR (adenosine deaminase that acts on RNA) enzyme family catalyze the hydrolytic deamination of adenosine to inosine within double-stranded RNAs, a poorly understood process that is critical to mammalian development. We have performed fluorescence resonance energy transfer experiments in mammalian cells transfected with fluorophore-bearing ADAR1 and ADAR2 fusion proteins to investigate the relationship between these proteins. These studies conclusively demonstrate the homodimerization of ADAR1 and ADAR2 and also show that ADAR1 and ADAR2 form heterodimers in human cells. RNase treatment of cells expressing these fusion proteins changes their localization but does not affect dimerization. Taken together these results suggest that homo- and heterodimerization are important for the activity of ADAR family members in vivo and that these associations are RNA independent.
Similar articles
-
Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.RNA Biol. 2018;15(7):976-989. doi: 10.1080/15476286.2018.1486658. Epub 2018 Jul 24. RNA Biol. 2018. PMID: 29950133 Free PMC article.
-
Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.Biochemistry. 2000 Oct 24;39(42):12875-84. doi: 10.1021/bi001383g. Biochemistry. 2000. PMID: 11041852
-
Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.J Biol Chem. 2003 May 9;278(19):17093-102. doi: 10.1074/jbc.M213127200. Epub 2003 Mar 4. J Biol Chem. 2003. PMID: 12618436
-
RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.Biochemistry (Mosc). 2019 Aug;84(8):896-904. doi: 10.1134/S0006297919080054. Biochemistry (Mosc). 2019. PMID: 31522671 Review.
-
ADARs and editing: The role of A-to-I RNA modification in cancer progression.Semin Cell Dev Biol. 2018 Jul;79:123-130. doi: 10.1016/j.semcdb.2017.11.018. Epub 2017 Nov 16. Semin Cell Dev Biol. 2018. PMID: 29146145 Review.
Cited by
-
Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):e2021757118. doi: 10.1073/pnas.2021757118. Proc Natl Acad Sci U S A. 2021. PMID: 33723056 Free PMC article.
-
Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.Front Genet. 2013 Jan 22;3:326. doi: 10.3389/fgene.2012.00326. eCollection 2012. Front Genet. 2013. PMID: 23346095 Free PMC article.
-
Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.J Biol Chem. 2019 Feb 1;294(5):1710-1720. doi: 10.1074/jbc.TM118.004166. J Biol Chem. 2019. PMID: 30710018 Free PMC article. Review.
-
Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures.Am J Hum Genet. 2020 Apr 2;106(4):467-483. doi: 10.1016/j.ajhg.2020.02.015. Epub 2020 Mar 26. Am J Hum Genet. 2020. PMID: 32220291 Free PMC article.
-
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.Virology. 2011 Mar 15;411(2):180-93. doi: 10.1016/j.virol.2010.12.004. Epub 2011 Jan 5. Virology. 2011. PMID: 21211811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials